Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-01-27
1989-06-13
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514275, 544331, 544333, 546 67, A61K 3148, C07D45702
Patent
active
048393630
ABSTRACT:
Ergoline derivatives of the formula I ##STR1## wherein R.sub.1 represents a hydrogen atom or a methyl group; R.sub.2 represents a hydrogen atom or a methoxy group;
REFERENCES:
patent: 2725384 (1955-11-01), Burness
patent: 4632928 (1986-12-01), Retlegi et al.
patent: 4657914 (1987-04-01), Bernardi et al.
patent: 4690929 (1987-09-01), Bernardi et al.
patent: 4713457 (1987-12-01), Ohno et al.
Bernardi et al., CA 74-42536n, 1971, "Methyl O-methyl-lumilysergati".
Krepelka et al., CA 98-179705g, 1983, "Ergotic alkaloids, LXVII, 8-substitution derivatives of D-6-methylergoline-I".
Roensch et al., CA107-40180t, 1987, "Preparation of oxazolidinylergolines".
Roensch et al., Ca 108-22135y, 1988, "Preparation of oxazolinylergolines as antihypertensive".
Rucman, Heterocycles, vol. 20, No. 11, 1983, pp. 2229-2232, "Thermal Decomposition of Dihydroergocristine Methanesulphonate".
Neef et al., J. Org. Chem., 1981, 46, pp. 2824-2826, "One step conversions of esters of 2-imidazolines, benzimidazolines, and benzothiazoles by aluminum organic reagents".
Crider et al., J. Med. Chem, 1977, vol. 20, No. 11, pp. 1473-1477, "Ergot Alkaloids, Synthesis of 6-alkyl-8-ergolines and 6-methyl-8-aminoergolines as potent prolactin inhibitors".
Krepelka et al., Collect. Czech. Chem. Commun., 48, 312-318 (1983).
Brambilla Enzo
Mantegani Sergio
Pegrassi Lorenzo
Rossi Alessandro
Temperilli Aldemio
Daus Donald G.
Farmitalia Carlo Erba
Shen Cecilia
LandOfFree
Ergolinyl heterocycles for the treatment of Parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ergolinyl heterocycles for the treatment of Parkinson's disease , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ergolinyl heterocycles for the treatment of Parkinson's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1277898